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ABSTRACT 
For patients with organ failure complications, organ transplantation is not always 
an option due to a shortage of donors along with obstacles such as risk of pathogen 
transfer and the possibility of immune rejection. Tissue engineering approaches based on 
cell therapy provide a promising alternative that could potentially solve these problems. 
The success of cell therapy for tissue repair and regeneration requires reliable and 
efficient cell delivery methods. Currently, hydrogels are favored matrices for cell 
delivery because of their ability to be injected by minimally invasive techniques as 
viscous liquids and crosslinked in situ under mild conditions compatible with the 
homogeneous incorporation of cells and bioactive molecules. However, hydrogels have 
several limitations including relatively weak mechanical properties that limit cell 
proliferation and allow premature contraction, as well as their hydrophilic composition 
that offers little capacity for binding secreted extracellular matrix (ECM) molecules to 
support higher order assembly. The long-term objective of this research is to develop a 
composite cell delivery matrix composed of a biosynthetic hydrogel containing porous, 
hydrophobic microparticles. Toward this end, the project examined optimization of 
processing variables to create porous Strataprene® 3534 polymer microspheres, 
examined their concentration-dependent effects on hydrogel physicochemical properties, 
and evaluated their ability to support cell adhesion. By decreasing polymer and 
increasing porogen concentrations, particles with increased porosity were attained. 
Hydrogel/particle composites maintained mechanical integrity with modest decreases in 
gelation efficiency and elastic modulus relative to hydrogel-only controls. Strataprene® 
iii 
3534 polymer films supported robust cell adhesion and spreading approximating tissue 
culture plastic controls and substantially greater than poly (lactide-co-glycolide) films. 
Cell adhesion to microparticles was less efficient, perhaps due to entrapment of 
poly(vinyl alcohol) used to stabilize the secondary emulsion on the surface of the 
microparticles. Overall, these studies demonstrate that highly porous polymer 
microparticles can be achieved and successfully incorporated into hydrogels to create 
composites without substantially altering the gel’s physical properties. Future studies will 
examine improvement of cell adhesion and composite functionality for enhancing cell 
proliferation and ECM accumulation.  
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INTRODUCTION AND BACKGROUND 
1.1 Advent of Tissue Engineering 
For a long time, organ transplantation was thought of as the only solution for most 
end stage organ failure based complications. The efficacy of this mode of treatment 
however was severely limited due to the ever widening gap between the number of 
prospective organ donors and patients placed on the organ transplant waiting list. In the 
United States, at the end of the year 2013 for example, there were 121,272 patients 
waiting for transplantation, while only 28,954 transplants were performed and organs 
from 14,257 donors were recovered [1].
Figure 1.1: Gap between number of donors and patients on waiting list [1] 
The reality as evidenced by Figure 1.1 is that the number of candidates waiting 
will continue to dwarf the number of donor organs available. There are also difficulties 
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such as the risk of pathogen transfer, possibility of immune rejection and steep costs 
associated with organ transplantation. This led to the birth of tissue engineering based 
approaches as an alternative method to address the limitations of organ transplantation.  
Tissue engineering is an interdisciplinary field that applies the principles of 
engineering and life sciences towards the development of biological substitutes that 
restore, maintain or improve tissue function (Langer and Vacanti 1993) [2]. This 
approach adopts three general strategies for the creation of new tissue [2] [3]. The first 
strategy involves the use of isolated cells from the patient or designing cell substitutes to 
perform specific function before infusion into the patient [2].  The second strategy 
involves the use of tissue inducing substances such as growth factors and the 
development of methods to deliver these molecules to their targets [2]. The third 
approach relies on cells being placed on or within matrices or scaffolds which act as a 
membrane to isolate the cells from the body while allowing permeation of nutrients and 
wastes. Such scaffolds are traditionally fashioned from natural material such as collagen 
or from synthetic polymers [2].  The success of tissue engineering depends on 
understanding tissue behaviors such as function and regeneration. 
1.2 Scaffold based Tissue Engineering 
For this project, we use a variant of the scaffold based cell therapy approach (first 
strategy) defined by Langer and Vacanti. This method involves a combination of viable 
cells, biomolecules and a structural scaffold which supports cell migration, growth and 
differentiation and guides tissue development and organization into a mature and healthy 





Figure 1.2: Overview of scaffold based tissue engineering approach [9] 
 
In theory, scaffolds in tissue engineering applications will have to meet certain 
minimum requirements for biochemical chemical and physical properties in order to fulfil 
their function. They must provide sufficient initial mechanical strength and stiffness to 
substitute for the mechanical function of the diseased or damaged tissue [4]. They need to 
maintain structural integrity during the growth and remodeling process [4] Scaffold 
architecture must allow for initial cell attachment, migration, mass transfer of nutrients 
and metabolites, and space for development and remodeling of tissue [4]. The 
degradation and resorption kinetics of the scaffold need to be tuned to the rate of tissue 
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development [4]. Ideally, as the scaffold is degraded, the cells will deposit their own 
extracellular matrix molecules that will eventually form three dimensional structures that 
closely mimic the native tissue architecture [5]. 
Some commonly used cell delivery systems for cell therapy at present include 
injectable porous polymeric microspheres and cell laden hydrogels. Injectable cell 
delivery methods are preferred to implantable methods as they would not require surgery 
and are minimally invasive [6] [5].  
1.3 Current microscale approaches in cell therapy 
 Porous polymeric scaffolds are extensively used in regenerative medicine 
(especially PLGA based) because they permit sufficient cell adhesion and survival. Also, 
PLGA is preferred because in certain applications it has already been FDA approved and 
has tunable degradation kinetics so as to match the rate of cell growth [5]. In order to 
promote tissue repair, scaffolds need to be mechanically stiff enough to promote cell 
proliferation and shielding of the cells from stresses experienced by the system in vivo 
during and after injection [7]. They must also have suitable mechanical properties and 
adequate porosity and pore diameter to support cell spreading, proliferation and migration 
in addition to nutrient delivery, waste removal and vascularization.  
It has been demonstrated in literature that both micro (<50 µm) and macro-
porosity (> 50 µm) is essential to influence tissue and cell function. If pores are too small 
cells can’t migrate in towards the center of the construct limiting the diffusion of 
nutrients and removal of waste products. Conversely, if pores are too large there is a 
decrease in specific surface area available limiting cell attachment [8]. Micropores 
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provide greater surface area for better cell adhesion, while macropores provide a larger 
void space for tissue regeneration in vivo when compared to non-porous PLGA 
microspheres [8]. Studies have shown that the ideal pore size is 3-5 times the size of the 
protein or cell they carry [8]. However, based on the application a balance must be found 
as increasing the porosity of a scaffold causes a decrease in mechanical properties [5].  
Porous polymeric scaffolds can be fabricated using a multitude of ways. Table 1.1 
provides a brief overview of some conventional fabrication techniques along with the 
corresponding pore size and porosity induced [4]. 
Table 1.1: Conventional fabrication techniques and corresponding porosity 
Technique Porosity (%) Pore size (µm) Material used 









<80 <10 PLGA, PLA 
 
Gas foaming method is based on inducing the formation of inert gas such as CO2 
within a precursor solution. The formed gas transforms the liquid into a foam entity. This 
foam can be stabilized by freezing the liquid phase with subsequent lyophilization. 
Solvent casting particulate leaching involves dissolving a polymer in an organic solvent 
along with sieved salt particles (sodium chloride). The solvent is then extracted by 
vacuum treatment followed by leaching out of salt particles by immersion in DI water. 
This method can be used to fabricate 2D scaffolds only a few mm thick. However, 
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neither of these methods allow for achievement of microporosity. The double emulsion 
solvent evaporation method however can be modified to obtain pore sizes in a wide range 
and can be used to fabricate microscaffolds for cell therapy. The double emulsion solvent 
evaporation method was used in this study to make porous polymeric microspheres. 
Briefly, micro-scaffolds were fabricated using a water/oil/water double emulsion solvent 
evaporation method using ammonium bicarbonate as a porogen.  In this technique a small 
aqueous phase (porogen in deionized water) is first emulsified within a polymer solvent 
phase. This emulsion is re-emulsified in a large volume of aqueous phase to generate a 
water in oil in water (W/O/W) double emulsion. The volatile solvent is removed as it 
diffuses into the aqueous medium and evaporates at the air water interface. As the solvent 
evaporates, the PLGA based microspheres are precipitated and collected by 
centrifugation [8]. 
Once the scaffolds with required size, porosity and pore diameter are fabricated 
by the suitable technique, the cells are loaded onto the scaffolds, and their viability, in 
vitro is determined before injection into the target site in a particular animal model to 
observe potential therapeutic effects. 
The other major cell delivery system utilizes hydrogels for tissue engineering. 
Hydrogels have long received attention as matrices for therapeutic cell transplantation 
based on their ability to be delivered using minimally invasive methods and crosslinked 
in situ under mild conditions [10]. They are also structurally and compositionally similar 
to extracellular matrix and can provide viscoelastic mechanical properties similar to 
many soft tissues. 
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Hydrogels for tissue engineering applications are generally prepared from either 
naturally derived or synthetic macromolecules. Hydrogels formed from naturally derived 
materials generally exhibit good cell adhesion and cell mediated enzymatic degradation, 
but end up lacking in terms of mechanical properties. They can end up undergoing rapid 
degradation unless stabilized by crosslinking agents. At the same time, hydrogels 
prepared from synthetic materials such as polyethylene glycol (PEG) allow for improved 
network physical and chemical properties but do not possess the bioactivity to support 
proper cell adhesion and cell mediated degradation [10] 
One commonly used approach to overcome this drawback associated with 
hydrogels has been the modification of synthetic networks with oligopeptides derived 
from natural ECM to support cell adhesion (e.g. RGD) and cell mediated degradation 
(e.g. MMP). Although, this method has found some success there are certain difficulties 
associated with the synthesis of oligopeptides, their reduced degradation kinetics and a 
tradeoff between bioactivity and mechanical properties during gel formulation [10]. 
An alternative approach involves the use of modified naturally derived 
macromolecules to form hybrid hydrogels which could potentially support higher rates of 
enzymatic degradation and better bioactivity and cell adhesion. It has been previously 
shown by our lab [10] semi-interpenetrating polymer networks (interlaced on a polymer 
scale without being covalently bonded) comprised of PEGDA and native HA show 
increased cell spreading and proliferation compared to synthetic networks as well as 
increased susceptibility to cell mediated enzymatic degradation due to the creation of HA 
enriched microdomains during the semi-IPN polymerization. These gels however, have 
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limited ECM binding properties due to the hydrophilicity of PEG, which is discussed in 
detail in Chapter 2. 
For this research study, the advantageous features of the PEGDA/HA semi-IPN 
and porous polymer microspheres were combined to provide improved cell therapy 
The therapeutic benefits of such scaffold based cell delivery systems however, is 
severely limited due to cell loss and cell death. Mechanical damage during injection, high 
leakage to surrounding tissues, improper vascularization and inflammation in the in vivo 
microenvironment could all contribute to poor cell retention and viability [7]. The lack of 
reliable cell delivery methods is one of the main problems that are preventing tissue 
engineering from realizing its true potential and showing significant clinical results. 
Traditional hydrogel or porous polymer microsphere based tissue engineering 
approaches also have limitations to their efficacy. Hydrogels are mechanically weak 
substrates which limit proper cellular spreading on the substrate, inhibiting subsequent 
proliferation and tissue development.  
At the same time polymeric microspheres are not as efficient as hydrogels for 
incorporation of cells. Their efficacy is also limited due to cell loss and cell death due to 
insufficient shielding from the stresses during injection and in the dynamic in-vivo 
environment. 
 In this study a novel hydrogel – porous polymer microsphere composite was 
developed that overcomes these drawbacks by using the hydrogel as a carrier for the cells 
and for stress shielding to maintain cell viability, while the porous polymeric 
 9 
microspheres suspended within the hydrogel provide a substrate with suitable mechanical 
properties for improved cell proliferation.  
Before the composite is discussed in detail, it is important to understand the effect 
of substrate mechanical properties on cell proliferation and the role of extracellular 
matrix in tissue development to better appreciate the functioning of our cell delivery 
system. 
1.4 Effect of substrate stiffness on cell proliferation 
 Most normal tissue cells are not viable when suspended in a fluid and are said to 
be anchorage dependent. These cells must adhere to a solid substrate in order to activate 
phenotypic functions for biological processes such as tissue cohesion, repair and 
proliferation.  
 Cells adhere to solid substrates that range in stiffness from soft to rigid and that 
also vary in topography and thickness. The stiffness of the substrate to which cells adhere 
can have a profound effect on cell structure and protein expression which has important 
implications for tissue development and regeneration [11]. At the cellular scale, normal 
tissue cells probe substrate elasticity as they anchor and pull on their surroundings. As a 
cell adheres to the substrate through focal adhesions, it pulls on the substrate via its actin-
myosin cytoskeleton, senses resistance, and in turn responds to this resistance through the 
cytoskeleton [12]. Such processes are dependent in part on myosin based contractility and 
transcellular adhesions centered on integrins, cadherins and other adhesive molecules to 
transmit forces to substrates [12] [13]. 
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Substrate stiffness has many effects on cell function. At the basic level, stiffness 
can regulate cell growth, viability and resistance to apoptosis. Fibroblast cell lines, for 
instance, undergo more apoptosis and less proliferation on soft as opposed to stiff 
substrates [12]. Stiffness can also regulate differentiation state, lineage commitment and 
the degree of cell matrix adhesion. The mechanical properties of the substrate to which 
cells adhere influences gene expression and post translational modifications at the most 
basic level [12].  
 
Figure 1.3: Effects of matrix mechanics on cell behavior [12] 
As shown in Figure 1.3, soft substrates (like lightly cross linked hydrogels) show 
diffuse and dynamic adhesion complexes in contrast to stiff substrates which show cell 
adhesion with stable focal adhesions. The cells adhering on soft materials probe substrate 
elasticity by pulling on the material. When they don’t sense sufficient resistance it can 
lead to substrate buckling. There are few focal adhesions in this case which limits the 
strength of cellular adhesion. As softer substrates don’t provide much resistance to the 
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actin myosin cytoskeleton, the cells exhibit a relatively round morphology. The cells 
adhering to stiff materials however, experience resistance when their actin myosin 
cytoskeleton pulls on the substrate. This leads to cytoskeletal changes causing a more 
spread morphology, which in turn activates cell proliferation. 
 Consistent with a role for signaling in stiffness sensing, tyrosine phosphorylation 
on multiple proteins (including paxillin) appears greatly enhanced in cells on stiffer 
substrates, whereas nonspecific hyperphosphorylation drives focal adhesion formation on 
soft materials [14]. Inhibition of actomyosin contractions, in contrast, largely eliminates 
prominent focal adhesions, whereas stimulation of contractility drives integrin 
aggregation into adhesions [14] 
The tactile sensing of substrate stiffness feeds back on cell adhesion, morphology 
and on net contractile forces. Cells on soft substrates are less contractile than on stiff 
substrates, which lead to their adhesion strength being lower as well [14].  
Thus, substrate stiffness which influences strength of cell adhesion to its 
extracellular environment is a crucial factor in any tissue engineering strategy as the 
strength of cell adhesion determines the maintenance of cell viability, rate of cell 
proliferation and in turn tissue development. 
1.5 ECM and its role in tissue development 
 The extracellular matrix represents the secreted product of resident cells within 
each tissue and organ and is made up of a mixture of structural and functional proteins 
arranged in a unique tissue specific three dimensional ultrastructure [4]. These molecules 
(mostly proteins) provide the mechanical strength required for proper tissue function and 
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act as a signaling mechanism between adjacent cells and between the cells and itself [4]. 
Most of the extracellular matrix molecules are well recognized and they form a complex 
mixture of proteins, glycosaminoglycans, glycoproteins and small molecules arranged in 
a tissue specific architecture. 
Collagen is the most abundant protein within the mammalian ECM constituting 
greater than 90% of its dry weight [4] [15]. More than 20 distinct types of collagen have 
been identified, each with a specific biologic function. Type I collagen (abundant in 
tendinous and ligamentous structures) for example, provide necessary strength to support 
the uniaxial and multiaxial mechanical loading to which these tissues are routinely 
subjected [15].  
 
Figure 1.4: Schematic representation of assembly of collagen I [4] 
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In the above figure (A) represents individual polypeptide chains consisting of 
repeating sequence Gly – X – Y (X, Y are often proline and hydroxiproline respectively), 
(B) Collagen is made up of three polypeptide strands which are left handed helixes, (C)  
Collagen molecules self-assemble into collagen fibrils, (D) Collagen fibers formed 
assembly of collagen fibrils [4]. 
Other major components of ECM include fibronectin, which is second only to 
collagen in terms of quantity within the extracellular matrix and is a dimeric molecule 
that serves as a ligand for adhesion of many cell types [4]. Laminin is another complex 
adhesion protein found in the ECM and plays and important role in early embryonic 
development [4]. Glycosaminoglycans are another component of the extracellular matrix 
that bind growth factors and cytokines (through heparin mediated binding), promote 
water retention and contribute to the gel properties of the ECM [4]. ECM also contains 
cytokines and growth factors (vascular endothelial growth factor, fibroblast growth factor 
etc.) in small quantities, which act as potential modulators of cell behavior. 
The ECM plays an intrusive role in cellular activities and can affect cellular 
behavior [16]. For example, the controlled interaction of cells with specific ECM 
architectures is critical to maintain cell phenotype [17]. The cell surface contains 
receptors capable of responding to extracellular signals. As soon as a ligand receptor 
interaction is established, the biochemical machinery involved in the control of gene 
expression starts [16].  
Cell adhesion is crucial for tissue formation and integrity. It is essential to know 
how cells interact with ECM and transduce extracellular stimuli into an intracellular 
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event to better understand tissue engineering strategies [18]. The identification of cell 
binding sites with extracellular molecules is a key step in studying cell – ECM 
interactions.  
The cell surface possesses non integrin and integrin receptors. Non integrin 
receptors consist of proteoglycans, CD36, and some laminin binding proteins. The most 
crucial receptors in cell binding however are the surface proteoglycans syndecan and 
CD44. Syndecan, in addition to binding collagens, fibronectin and thrombospondin binds 
bFGF (basic fibroblast growth factor). Syndecan is unique in the sense that it can co-
localize both ECM molecules and growth factors to the cell surface and assemble 
signaling complexes with other receptors [16]. CD44 plays a vital role in cell adhesion 
and movement by binding type I and IV collagens and hyaluronan [16]. 
Integrins represent a large group of glycoprotein cell surface receptors [19]. When 
ECM molecules bind to a specific integrin receptor, a change in cytoplasmic domain of 
the receptor occurs associating the cytoskeleton at focal adhesion sites [19, 20]. This 
leads to an assembly of focal contact proteins with intracellular components such as 
phosphorylated proteins [20]. These changes can promote cytoskeletal rearrangement, 
which may alter the interactions of chromatin and nuclear matrix at the nuclear level [16]. 
This dynamic association of integrin receptors with actin cytoskeleton may also induce 
changes in cell shape, altering the ability of the cells to proliferate or differentiate [16]. 
There are two main ways in which the extracellular matrix can influence cell 
behavior. One of these is through cell – ECM interactions which may directly regulate 
cell functions through receptor mediated signaling [16] [18]. It has been shown in 
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literature that the molecules able to regulate cell adhesion can modulate the cellular 
response to other extracellular stimuli [21]. These ECM molecules may selectively 
stimulate specific types of signal transduction pathways that may affect cell proliferation 
and differentiation as a downstream effect. The second way in which the extracellular 
matrix may affect cell function is by mobilizing growth or differentiation factors on the 
cell surface (ECM – growth factor interactions), thus modulating cell proliferation and 
cell phenotype [16]. 
Thus, the extracellular matrix molecules play a crucial role in cell adhesion, 
proliferation, and tissue development and can be thought of as one of the main indicators 
of the efficacy of scaffold based cell therapy. The more extracellular matrix deposition 








2.1 Project Rationale and Hypothesis 
 As mentioned in previous chapters, semi-interpenetrating polymer 
networks comprised of polyethylene glycol diacrylate (PEGDA) and native hyaluronic 
acid (HA), show increased cell spreading and proliferation compared to synthetic 
networks as well as increased susceptibility to cell mediated enzymatic degradation due 
to the creation of HA enriched microdomains during the semi-IPN polymerization. 
Despite the success of this approach, there are still limitations to cell therapy due to the 
protein repelling properties of PEG. 
The inertness of PEG towards protein adsorption is due to its hydrophilicity, chain 
mobility and lack of ionic charge.  The PEG backbone is mostly hydrogen bonded to 
water molecules that form a partially structured hydration layer. Adsorption of protein 
molecules requires the disruption of this layer. Protein adsorption also leads to the 
compression of the PEG layer which is entropically unfavorable. These features have led 
to several groups using PEG as a modifier to create a biocompatible but cell repelling 
surface. Thus, PEG based hydrogels used for cell therapy do not provide adequate 
capture of extracellular matrix proteins to allow for higher order assembly which is a 
crucial step in cell proliferation and subsequent tissue regeneration [22] [23] [24].  
Hydrogels also possess relatively weak mechanical properties, which leads to 
cells forming diffuse and dynamic focal adhesions with low strength on the hydrogel 
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surface. This limits the extent of cytoskeletal rearrangement (cell spreading on substrate), 
and the rate of cell proliferation necessary to ensure efficient cell therapy. 
Porous microspheres provide certain benefits by virtue of their mechanical 
properties. These particles are generally stiffer than hydrogels and cells form stable focal 
adhesions on their surface with spread morphology. This leads to higher rates of cell 
proliferation when compared to hydrogels. PLGA based microparticles can also 
effectively bind ECM molecules secreted by cells by virtue of their hydrophobicity. It 
was hypothesized that the benefits afforded by porous microparticles can be maximized 
by using a novel Strataprene® 3534 polymer synthesized by Poly-Med, Inc. due to its 
suitability for the cell scaffold application. Some key features of this polymer we are 
looking to exploit include:  
1) It is a copolymer with repeat units with significantly more compliant than lactide and 
glycolide monomers, so it has improved mechanical properties when compared to 
traditionally used PLGA.  
2) The degradation byproducts are less acidic than most traditionally used polymers, thereby 
improving the environment for cell growth. 
 3) The polymer by virtue of its structural differences compared to PLGA promotes better 
cellular attachment. 
Based on the properties of porous microspheres, it was hypothesized that adding 
porous Strataprene® 3534 polymer microspheres to hydrogels would overcome the 
limitations associated with gels by: 
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1) improving mechanical properties at the micro level in the hydrogel enabling better cell 
proliferation.  
2) providing hydrophobic domains able to bind and effectively capture extracellular 
matrix, thereby enhancing matrix accumulation and tissue growth. 
 The long term objective of this proposed research was to develop a hydrogel – 
porous polymer microsphere composite system for efficient cell therapy. First, porous 
Strataprene® polymer microspheres will be fabricated using a double emulsion solvent 
evaporation method with ammonium bicarbonate as a porogen [25]. The process 
variables will be optimized until the microspheres are characterized to have the 
appropriate diameter, pore size and porosity for our application by using scanning 
electron microscope [25] [26]. 
Next, a Polyethylene glycol diacrylate (PEGDA) macromere blend of PEG-bis-
(acryloyloxy aceteate), PEG-bis-(acryloyloxy proponoate) and PEG-bis-(acryloyloxy 
butyrate) with hyarulonic acid and varying concentrations of porous polymeric 
microspheres was photopolymerized under a low intensity UV lamp to create the 
composites [27]. These composites with varying concentrations of microparticles were 
then mechanically characterized and their elastic moduli and gelation efficiencies were 
compared with hydrogel only controls.  
Finally, cell adhesion properties of Strataprene® 3534 polymer films were 
compared with tissue culture plastic and  poly (lactide-co-glycolide) (PLGA) controls 
followed by the evaluation of cell adhesion properties of the porous polymer microsphere 
component of our composite system. 
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Specifically, the composite was fabricated and its efficacy for cell therapy was 
evaluated using three aims: 
2.2 Aims 
Aim 1: Fabricate and characterize Porous Strataprene® 3354 polymer microspheres with 
appropriate diameter, pore size and porosity. 
Aim 2: Develop and mechanically characterize a photo crosslinked hydrogel made from 
a PEGDA macromer blend. 
Aim 3: Test cell adhesion properties of the polymer microsphere - hydrogel composite 









MATERIALS AND METHODS 
3.1 Materials 
Strataprene® 3534 polymer (35/34/17/14 Caprolactone/L-
Lactide/Glycolide/Trimethylene Carbonate Polyaxial Block, Random Copolymer) (Mw 
165±5 kDa) was generously donated by Poly-Med Inc. (Anderson, SC). Poly (lactic-co-
glycolic acid) (PLGA) (74:26, I.V. 0.90 dl/g) was contributed by Purac BU Biomaterials 
(Gorinchem, Netherlands). Poly vinyl alcohol, Dichloromethane (HPLC grade), 
anhydrous dimethylformamide (DMF) and sodium bicarbonate were obtained from Acros 
organics (NJ, USA). Polyethylene glycol (PEG) was purchased from Fluka (Buchs, 
Switzerland). 2-chloropropionyl chloride, trimethylamine, sodium acrylate, 4-
methoxyphenol, were purchased from Sigma-Aldrich (St Louis MO, USA). Ethyl ether, 
sodium sulfate and ammonium bicarbonate were purchased from Fisher Scientific (NJ, 
USA). Irgacure 2959 9@-hydroxy-1-{4-(hydroxyethoxy) phenyl]-2-methyl—propanone, 
I-2959) was purchased from Ciba® Specialty Chemicals (Basel, Switzerland). A dog 
bone shaped mold for photopolymerization of hydrogel for tensile testing was 3-D 
printed using KLIC-N-PRINT 3D printer.     
 Alexa Fluor® 594 phalloidin molecular probe was purchased from Life 
Technologies (OR, USA). Fluorescein diacetate was purchased from Thermo Fisher 




3.2 Fabrication of porous polymer microspheres 
 Porous Strataprene® 3534 polymer and PLGA control microspheres were 
fabricated using a double emulsion solvent evaporation method. The process variables 
were optimized until the microspheres were characterized to have the appropriate 
diameter, porosity and pore size using scanning electron microscope. 
3.2.1 Double emulsion solvent evaporation method 
 Porous microspheres were created using a water in oil in water double emulsion 
method as shown in Figure 3.1. In the baseline fabrication process, 500 mg of ammonium 
bicarbonate (porogen) was dissolved in 2.5 ml deionized water. This water phase was 
then added to a solution of 500 mg of Strataprene® in 8 ml of dichloromethane. This 
primary emulsion (W/O) was homogenized using the Sonic Ruptor 400 (Omni 
International,) ultrasonic homogenizer at a power output of 40 % in the pulse mode 
(80%) for 3 minutes. This water/oil emulsion was immediately transferred to a beaker 
containing 300 ml of 0.1% (w/v) polyvinyl alcohol on a stir plate at 450 rpm for 4 hours. 
The microspheres were filtered between two sieves of mesh size 140 (100 microns) and 
40 (425 microns) and washed five times with distilled water. Aliquots of the sample for 
scanning electron microscopy were then lyophilized (FreeZone® 4.5 ©Labconco freeze 
dry system) for 3 days [25].  
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Figure 3.1: Illustration of double emulsion solvent evaporation method [26]  
Nine more sets of microspheres with varying process parameters were fabricated 
to identify the effects of each variable and for the optimization of the process to obtain 
microspheres with the desires diameter, pore size and porosity as shown in Table 3.1: 


















1 8 ml 500 mg 500 mg 2.5 ml 450 rpm 
2 8 ml 500 mg 600 mg 2.5 ml 450 rpm 
3 8 ml 500 mg 600 mg 3.5 ml 450 rpm 
4 8 ml 500 mg 840 mg 3.5 ml 450 rpm 
5 8 ml 400 mg 600 mg 2.5 ml 450 rpm 
6 8 ml 600 mg 600 mg 2.5 ml 450 rpm 
7 7 ml 500 mg 600 mg 3.5 ml 450 rpm 
8 8 ml 500 mg 600 mg 2.5 ml 300 rpm 





3.2.2 Scanning electron microscopy 
 
 Field emission scanning electron microscopy was used to observe the 
microsphere’s surface morphology, diameter and pore sizes. Lyophilized samples were 
fixed onto an aluminum SEM stage using double sided carbon tape and sputter coated 
with platinum at 15 milliamps current with Hummer 6.2 Platinum sputtering system for 
approximately 2 minutes. Using the microscope S 3400N (Hitachi, AMRL-Clemson 
University), preliminary images were taken with an accelerating voltage of 10.0 kV. 
Once the parameters had been optimized the final high resolution images at 60x, 180x 
and 300x magnification were taken using SU 6600 (Hitachi, AMRL) with an accelerating 
voltage of 10.0 kV and a 10 mm working distance. 
3.2.3 Preparation of uniform microsphere suspensions 
 The uniformity of the suspension of porous polymeric microspheres was assessed 
under various conditions. First, a batch of microspheres fabricated by the double 
emulsion solvent evaporation method were freeze dried and then aliquots of 12 and 18 
mg were weighed out in 1.5 ml microcentrifuge tubes.  The particles were then suspended 
in 1 ml of 1X PBS and vortexed for 2-3 minutes. The microspheres were then suspended 
in 1 ml of 1X PBS without freeze drying. This was followed by making a 1 ml 
suspension of the microspheres was made along with 0.36% hyaluronic acid in 1X PBS 
and left on the vortex at speed 8 overnight. Finally, freeze dried microspheres were 




3.3 Hydrogel preparation 
 The next phase of our study involved the preparation of a semi interpenetrating 
polymer network made from a PEG diacrylate macromer blend of PEG-bis-(AA), PEG-
bis-(AP) and PEG-bis-(AB) (12.5%:37.5%:50%) with hyarulonic acid and varying 
concentrations of the polymer microparticles (0, 12 & 18 mg/ml). These gels were then 
mechanically characterized using tensile tests and their gel swelling behavior was 
observed by calculating gel and equilibrium water content. 
3.3.1 Preparation of degradable, crosslinkable PEG diacrylate macromers 
 A previously described semi-IPN composed of a PEGDA macromere blend of 
PEG-bis-(acryloyloxy aceteate), PEG-bis-(acryloyloxy proponoate) and PEG-bis-
(acryloyloxy butyrate) with hyarulonic acid, that supports 3D cell spreading/migration 
was selected as a model gel for these studies [10] [27] [28]. Through varying the alkyl 
content of the chemical intermediary, hydrogels with varying degradation rates were 
shown to be formed. 
PEGDA macromers with degradable ester bonds were made using a two-step 
reaction as shown in Fig 3.2: 
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Figure 3.2: Preparation of degradable PEG-bis-acrylate macromers [29] [30] 
 PEG-bis-(AA) and PEG-bis-(AB) were provided by Dr. Ho-Joon Lee who 
synthesized them previously, while PEG-bis-(AP) was synthesized as follows.  
3.3.2 Synthesis of PEG-bis-(acryloyloxy propanoate) 
  All glassware was cleaned in a NaOH/Ethanol (500g in 5L) and dried in a 
vacuum oven overnight. PEG-bis-(acryloyloxy propanoate) was prepared by reacting the 
terminal hydroxyl groups on PEG with (2-chloropropinoyl chloride). 15 grams of PEG 
(MW 3934g) was dissolved in 120 ml of dichloromethane dehydrated using calcium 
hydride.  The amount of 2-chloropropinoyl chloride and triethylamine (TEA) to be added 
to the reaction solution were calculated using the formulae: 
 
Volume of 2-CP = (the weight of PEG/ MW of PEG) * MW of 2-CP 
Density of 2-CP 
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Volume of TEA = 1.8*(the weight of PEG/ MW of PEG) * MW of TEA 
Density of TEA 
 TEA was then added to the reaction flask which was cooled on an ice bath. 2-
chloroproionyl chloride was then dissolved to 30ml of dehydrated dichloromethane and 
added dropwise with an addition funnel to the reaction flask over 2 hours. The ice bath 
was then removed and the reaction was continued at room temperature for 24 hours. The 
reaction mixture was filtered using a fine funnel to remove the TEA-HCl salt, and then 
concentrated by rotary evaporation (Buchi Rotovapor®, Switzerland). The residue was 
redissolved in 150 ml of dichlormethane and washed 3-4 times with 15 ml of 10% 
sodium bicarbonate solution until the pH of the solution was neutral. The solution was 
then dried using anhydrous sodium sulfate. The solution was concentrate one more time 
by rotary evaporation and precipitated in 200 ml ethyl ether (-20°C), and washed 3 times 
with cold ethyl ether.  The final product of this step (Product I) was separated by 
filtration and stored in vacuum desiccator for 24 hours. 
 In the second step of this process, the product obtained in the previous step was 
added to a flask containing dimethylformamide (10 times amount of product I) being 
purged with argon continuously. Once the product had dissolved, a small amount of 4-
Methoxyphenol was added and an oil bath with the reaction flask submerged in it was 
heated to 85°C. Sodium acrylate {(5*[(weight of product I)/ Mw of product I]*Mw of 
sodium acrylate} was then added and a condenser column is connected to the flask. This 
reaction was allowed to run for 30 hours. The solution was then filtered and concentrated 
using the rotary vacuum evaporator (Buchi V 700 vacuum pump) at 55°C and 11 mbar 
vacuum. The solution was then precipitated in 400 ml of ethyl ether(-20°C) and washed 3 
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times with cold ethyl ether. The final product PEG-bis-(acryloyloxy propanoate) was 
gathered by filtration and stored in the vacuum desiccator for 24 hours.  
The structure of the product in both steps was determined by 1H-NMR (Bruker 
Avance-300MHz) using deuterated chloroform as a solvent and compared with the NMR 
results obtained for the same products by previous reports in literature [28] [29]. 
3.3.3 Hydrogel photopolymerization 
 A PEG diacrylate macromer blend of 12.5% PEG-bis-(AA), 37.5% PEG-bis-(AP) 
and 50% PEG-bis-(AB) at 30 % w/v concentration was made. From this blend a working 
solution of 6% w/v PEGDA solution with 0.36% HA (MW 1.50MDa), 0.1% w/v I-2959 
photoinitiator and varying concentrations of the polymer microparticles (0, 12 and 18 
mg/ml) in 1 X PBS (0.1M, pH 7.4) was made. This solution was pipetted between two 
microscopic glass slides separated by mm Teflon spacers and clamped together with 
clips. The slides were then placed under a low intensity UV lamp (B 100 AP of Blak-
ray®, wavelength 365 nm, intensity 15mW/cm2). The glass slides were separated 
carefully after pipetting PBS around the gel. Disc shaped gels were then cut out using a 
hole punch (5/6 inch). 
3.3.4 Gel content and swelling behavior 
 After photopolymerization, the hydrogel discs were collected in microcentrifuge 
tubes and placed in the -80 freezer for 4 hours. The samples were then moved to the 
lyophilizer (FreeZone® 4.5 Benchtop freeze dry systems of ©Labconco) overnight and 
then weighed (Dw1). The discs were placed in separate scintillation vials containing 4 ml 
of 1 X PBS and allowed to swell at room temperature overnight. The samples were then 
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collected, blotted on Kimwipes to get rid of excess superficial liquid and weighed 
(Ww2).  The samples were freeze dried overnight one more time and weighed one more 
time (Dw2). The gel and equilibrium water content were calculated using the formulae 
[29]: 
 Gel content (%) = (Dw2/Dw1) * 100 
 Equilibrium water content (%) = [(Ww2 – Dw2)/Ww2] * 100 
3.3.5 Uniaxial tensile testing 
 A dog bone shaped mold with 5 mm width and 1 mm depth was designed using 
SolidWorks 3D printed. The PEGDA macromere blend previously specified along with 
varying concentrations of polymer microparticles (0, 12 and 18 mg/ml) were injected into 
 the mold clamped between two microscopic glass slides and photopolymerized under a 
low intensity UV lamp (B 100 AP of Blak-ray®) for 5 minutes on each side like before.  
 The dog bone shaped gels were obtained from the mold and equilibrated in 1 X 
PBS overnight. The samples were subjected to tensile testing using a MTS Synergie 100 
(MTS Systems Corp.) material testing system. TestWorks® 4 software was used to 
interpret the data. A 10N load cell was used to subject the gels to 30% strain at 10 
mm/min. Each sample was tested three times to ensure slippage did not occur. The data 
acquisition rate was set at 500 Hz. The sample ends were covered with small pieces of 
Kimwipe to ensure clamping stability. 
The load exerted, extension, stress, strain and elastic modulus values were 
displayed by the software based on the thickness, width and grip separation inputs 
provided by the user. However, these values might not have been completely accurate 
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because the lower limit for width of cross section on the MTS Synergie 100 system was 
5.080 mm and there was a zero error of 0.723 N loading force.  So, manual calculations 
were made for the values of Young’s moduli as the slope of the stress strain plot at 
random points in the linear elastic region between 0 and 20 % strain [29]. 
3.3.6 Statistical analysis 
The data obtained for mean diameters and pore sizes of baseline [25] and 
optimized porous microspheres, gel content, equilibrium water content and elastic moduli 
were compared by ANOVA [31]. The final results were presented in terms of mean ± 
standard deviation. 
3.4 Cell adhesion studies 
 In this part of the study, preliminary tests to establish the proof of concept of our 
composite system were performed. In the first test rat fibroblast cells were seeded onto 
spin coated microscopic glass slides for 24 hrs followed by cell fixation and staining to 
assess cell adhesion properties of the Strataprene® material. This was followed by live 
staining of rat fibroblast cells seeded onto the porous polymer microsphere (24 hour 
duration) component of our composite to observe cell adherence and viability in vitro. 
3.4.1 Cell culture 
 Rat fibroblast cells were obtained from rat heads dissected in our lab. The cells 
were cultured routinely in T – 175 cell culture flasks using DMEM F-12 50/50, 1X, with 
L- glutamine and 15mM HEPES with 10% (v/v) bovine growth serum and 50 U/ml 
penicillin and 50µg/ml streptomycin [27]. The media was changed every three days and 
cells were passaged upon reaching about 80 % confluence. For cell seeding purposes, the 
 30 
cells were trypsinized, centrifuged, resuspended in media and counted using a 
hemocytometer to ascertain the concentration of cells in a 5 ml volume. Based on the cell 
density required, the volume required to be pipetted from our cell suspension was 
calculated. 
3.4.2 Cell adhesion on spin coated glass slides 
 Microscopic glass slides were cut to a length of 2.5 cm using a diamond tipped 
glass scribe. The slides were spin coated with 5% (w/v) PLGA and 7% (w/v) 
Strataprene® 3534 polymer in dichloromethane solution by Dr. Guzeliya Korneva. The 
slides were then left in a vacuum oven for 48 hours to get rid of the DCM. Finally, these 
slides were placed in 6 well plates and sterilized under ethylene oxide for 24 hours. These 
glass slides were prepared with the help and on facilities supported by NIGMS of the 
National Institutes of Health under award number 5P20GM103444-07 
 The spin coated glass slides were seeded with rat fibroblast cells at a density of 
50,000 cells per well and cultured in media for 24 hours. The cells were fixed using 4% 
paraformaldehyde, permeabilized using 0.1% Triton X -100. Cells are then stained with 
DAPI (4,6-diamidino-2-phenylindole) which is a fluorescent dye that binds strongly to 
the A-T rich regions in DNA and can be used to visualize cell nuclei. This followed by 
cell staining with red fluorescent phalloidin dye that selectively labels F – actin in fixed 
cells. The cells were then observed and imaged using a fluorescence microscope. 
3.4.3 Cell seeding experiment 
 The microspheres fabricated using the double emulsion solvent evaporation 
method were suspended in sterile deionized water and centrifuged 4 times at 4000 rpm 
 31 
for 5 mins. The particles were then sterilized under UV light in a petri dish under the cell 
culture hood overnight. 
 The sterilized porous Strataprene® polymer microspheres were transferred to a 24 
well plate and seeded with rat fibroblast cells in media for 24 hours in the incubator. A 
live Fluorescein diacetate stain was performed to observe cell viability and adhesion to 
the polymer microsphere component of our composite. Live cells take up the non-
fluorescent FDA and convert it into fluorescent metabolite fluorescein. This conversion is 
esterase dependent and thus serves as an indicator of cell viability [32] [33] [34]. The 
















RESULTS AND DISCUSSION 
 4.1 Double emulsion solvent evaporation 
 The first stage of this study involved the use of a double emulsion solvent 
evaporation method for the fabrication of porous Strataprene® 3534 polymer 
microspheres. This process has a lot of variables which affect the microsphere diameter, 
pore sizes and porosity in a multitude of ways. The long term goal of this study is to be 
able to inject these microspheres in vivo through 18 gauge needles to achieve cell 
therapy. For this application the microspheres would need to have both micro (< 50µm) 
and macroporosity (>50µm). As mentioned earlier, the ideal pore size for a scaffold is 3 – 
5 times the size of the cells seeded on them. So, for efficient injectability and cell 
seeding, the microspheres would have to be in the 300 – 450 micrometer range with a 
pore size in the 30 – 70 µm range (Since, most mammalian cells are in the 10 – 25 µm 
range) [8]. The microspheres must also have an open interconnected porosity to support 
cell migration into the scaffold along with ECM infiltration and tissue ingrowth. A 
number of batches with varied parameters were then fabricated and characterized until 
the microsphere features were deemed optimal for our application.  
4.1.1 Optimization of process variables 
For the first baseline fabrication batch, we used PLGA instead of Strataprene® so 
as to eliminate the variability due to polymer when comparing with microsphere SEM 
images from literature [25] [35] [36] [37]. The parameters used were based on work done 
on macroporous PLGA microspheres by Kang et. al (2007) [25]. The microspheres were 
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fabricated by the double emsulsion solvent evaporation method previously described 
using 500 mg of PLGA dissolved in 8 ml of methylene chloride and 500 mg of  porogen 
in 2.5 ml DI. These baseline microspheres were then washed, freeze dried and 
characterized using scanning electron microscopy. 
 
Figure 4.1: Baseline porous PLGA polymer microspheres (500 mg of PLGA 
in 8 ml of DCM and 600 mg of porogen in 2.5 ml DI water at a stir rate of 450 rpm) 
 The microspheres obtained with these set of conditions were mostly in the 
300 – 450 µm range, which is an appropriate range for injectability through an 18 gauge 
needle. The pore sizes for the baseline batch however were in 20 – 40 µm range. There 
wasn’t any macroporosity (> 50 µm) to support tissue ingrowth. Also, most of the 
porosity appeared to be present superficially on the surface. There didn’t appear to be 
much pore interconnectivity either.  
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Based on a literature study [38] [39] [40] performed to identify the effects of 
process variables, we isolated stir rate, polymer concentration, porogen concentration, 
solvent volume of inner aqueous phase and of organic solvent phase as key factors 
affecting microsphere diameter, pore size and porosity.  
 Nine more sets of microspheres with variations in process variables as 
demonstrated in table 3.1 were made.   
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Figure 4.2: Montage of sets of microsphere with varied fabrication conditions, from 
top left corner to bottom right corner; FC 1 to FC 9  
Scale bar: 100 um 
 The microspheres made with the parameters described by Table 3.1 were freeze 
dried and characterized by SEM. 
 Microspheres from fabrication condition 1 used the baseline parameters obtained 
from literature [8] to fabricate porous Strataprene® microspheres.  The microspheres 
obtained in this case were mostly in the 300 – 450 µm range, but their pore sizes were in 
the 12 – 28 µm range. The microspheres also didn’t possess an open porous structure as 
most of the pores were present the surface. There wasn’t any macroporosity (> 50 µm) to 
support tissue ingrowth either. 
For FC 2 the only change was increasing the concentration of porogen. The 
microspheres in this case showed on average larger pore sizes than the baseline batch. 
However, the porosity was still limited to the surface and macroporosity could not be 
observed either. In, the next fabrication (FC 3) we increased the porogen solvent 
(deionized water) from 2.5 ml – 3.5 ml while maintaining the amount of porogen at 
600mg. In this case greater numbers of pores were observed although there wasn’t any 
significant difference in the average pore sizes or any macroporosity. For FC 4, the 
volume of DI water was maintained at 3.5 ml, while increasing the amount of porogen 
from 600 to 840 mg. There was a slight increase in the porosity and average pore size in 
this scenario. However, these microspheres did not exhibit any macroporosity. 
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For fabrication FC 5, the polymer concentration was reduced from 500 mg to 400 
mg in 8 ml of dichloromethane and 600 mg of porogen was dissolved in 2.5 ml of 
deionized water. In this case, the microspheres exhibited much larger pore sizes in the 30 
– 65 µm range with adequate macroporosity. The microsphere diameters were also in the 
desired range of 300 – 400 µm. These microspheres demonstrated an open interconnected 
structure with micro and macroporosity and were considered to be the batch most suitable 
for our application. These microspheres were designated as the final batch with the 
optimized parameters. 
 
Figure 4.3: FC 5 Stratprene® microspheres (400 mg of Strataprene® in 8 ml 
of DCM and 600 mg of porogen in 2.5 ml DI water at a stir rate of 450 rpm) with 
optimized parameters 
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For FC 6, we increased the polymer concentration from 500 mg to 600 mg in 8 ml 
of dichloromethane. The remaining parameters were the same as batch 5. Increasing, the 
polymer concentration led to a drastic decrease in average pore size. There also seemed 
to be an increase in average diameter of the microspheres in this case. For fabrication 
condition 7, we decreased the organic solvent volume from 8 ml to 7 ml while increasing 
the volume of deionized water from 2.5 to 3.5 ml. The amount of polymer and porogen in 
this case were 500 mg and 600 mg respectively. The microspheres in this case didn’t 
have any macroporosity. The microspheres in this batch generally seemed to have 
slightly larger pore size and diameter when compared to FC 3. For FC 8, we reduced the 
stir rate from 450 rpm to 300 rpm. All the other parameters were kept the same as FC 2. 
The microspheres in this case had larger diameters on average with a few microspheres 
being as large as 700 µm. The pore sizes also seemed slightly larger than the other 
batches with 500 mg of polymer. The porosity was still limited to the surface however 
and there was an absence of macroporosity. For fabrication of FC 9, we increased the stir 
rate to 600 rpm while keeping all other parameters the same as FC 8. The microspheres 
were significantly smaller and had pore sizes mostly in the 8 – 24 µm range. 
Based on the observations made above from the different microsphere batches it 
was inferred that microsphere diameter is affected primarily by stir rate and to a lesser 
extent polymer concentration. Similarly, the pore size was characterized to have been 
affected most by porogen concentration, stir rate and to a lesser extent the volume of 
deionized water. Macroporosity and pore interconnectivity seemed to be most affected by 
polymer concentration. 
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4.1.2 Statistical analysis of baseline and optimized Strataprene® microspheres 
 SEM images of FC 1 and FC 5 were used to calculate the mean diameters and 
pore size for the baseline and optimized microspheres. The microsphere diameter for both 
batches seemed to be in the same range. There was a significant difference in the average 
diameters of the two batches however with the mean diameter of the optimized 
Strataprene® microspheres being more than twice that of the baseline batch. 
Table 4.1: Pore sizes and Diameters of baseline and optimized microspheres 
 Baseline (FC 1) Optimized (FC 5) 
Microsphere diameter 355.93 ± 48.10 353. 47 ± 50.84 
Pore size 21.73 ± 8.67a 44.39 ± 18.98a 
 
a represents a significant difference between two microsphere fabrication conditions 
 
4.1.3 Preparation of uniform microsphere suspensions 
 Freeze dried microspheres suspended in 1 ml of 1X PBS would float to the top 
and form aggregates that would not go into suspension following vigorous vortexing 
(Vortex Genie-2, Scientific industries) 
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Figure 4.4: Freeze dried Strataprene® microspheres (FC 5) in 1X PBS a) 5, b) 10 
and c) 20 seconds after vortexing. 
 Non freeze dried microspheres suspended in 1 ml of 1X PBS would settle to the 
bottom of the tube almost instantaneously. The particles would temporarily form a 
uniform suspension upon vortexing but the suspension would become non uniform by the 
time the lid was opened to pipette out a certain volume. 
        
Figure 4.5: Non-freeze dried Strataprene® microspheres (FC 5) in 1X PBS a) 5, b) 
20 and c) 90 seconds after vortexing 
 A 1 ml mixture of the microspheres along with 0.36% HA in 1X PBS vortexed at 
speed 8 overnight formed a suspension that stayed uniform for 20 minutes at a time. 100 
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microliters was pipetted from the suspension and freeze dried overnight. The dry weight 
of the microparticles was then determined based on which the concentration of 
microspheres in the stock suspension was estimated 
        
Figure 4.6: Non-freeze dried Strataprene® microspheres (FC 5) with 0.36% 
HA in 1X PBS a) 1, b) 45 and 360 minutes after vortexing 
 
Freeze dried Strataprene® microspheres (FC 5) treated with ethanol (30 mins) and 
suspended in 1 ml of 1X PBS would form aggregates that would float to the top and not 
go into suspension following vigorous vortexing.  
4.2.1 Synthesis and characterization of PEG-bis-(acryloyloxy propanoate) 
 In the first step, the PEG hydroxyl groups react with the acid chloride group on 2-
chloropropionyl chloride to form ester bonds and terminal alkyl groups separated by a 
variable alkyl spacer.  This was followed by the addition of terminal acrylate esters to the 
intermediate products by nucleophilic substitution reaction between the terminal alkyl 
chloride groups and sodium acrylate. 
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  Following synthesis, the structure of PEG-bis-(AP) was confirmed by NMR 
spectroscopy. The NMR result of the PEG-bis-(AP) product was in accordance with 
results obtained for the same product previously synthesized by Dr. Eunhee Cho.  
1H-NMR peaks detected and representative spectra for PEG-bis-(acryloyloxy 
propanoate) using deuterated chloroform as a solvent are shown in Figure 4.7 
{T= 1.65-1.75 (d, -CH3), 3.-3.7 (m, -(CH2CH2O)n-), 4.3-4.4 (t, -CCH2OC(=O)-), 4.4-




Figure 4.7: Structure and 1H-NMR spectrum of PEG-bis-(acryloyloxy propanoate) 
4.2.2 Gel content and swelling behavior 
 . The gel contents and the equilibrium water contents of the different batches are 
shown in Table 4.3.  Both gel and equilibrium water content were consistently high at 
different microsphere concentrations (0, 12 and 18 mg/ml). There was also a slight 
increase in equilibrium water content with increase in microsphere concentration. This is 
consistent with a slight decrease in crosslinking density due to the presence of 
microspheres that are not covalently incorporated in the gels. This decrease in 
homogeneity of the gel could also account for the decrease in gel content with increasing 
microsphere concentration. Overall, there was only a slight decrease in gelation 
efficiency with an increase in concentration of microspheres up to 18 mg/ml [29] [41]. 
 
Table 4.2: Gelation efficiency 
Microsphere concentration Gel Content (%) Equilibrium water content (%) 
0 mg/ml 96.66 ± 1.15a 93.31 ± 0.29a 
12 mg/ml 92.11 ± 4.3a 94.14 ± 0.27a 
18 mg/ml 91.36 ± 2.6 94.46 ± 0.1 
 
a represents a significant difference between two microsphere concentrations 
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4.2.3 Uniaxial tensile test 
 The mechanical properties of the gels are given below. Tensile testing showed 
that the elastic modulus of the gels decreased with increasing microsphere concentration. 
The hydrogels prepared without any microspheres were found to be the stiffest and had 
an elastic modulus of 47.78 ± 6.77 kPaa. Increasing the microsphere concentration to 12 
mg/ ml led to a decrease in elastic modulus of the gels by about 12 kPa (35.68 ± 3.62 
kPaa). Hydrogels with a microsphere concentration of 18 mg/ml showed the lowest 
elastic modulus (26.43 ± 2.04 kPaa) (a represents a significant difference in elastic moduli 
between two microsphere concentrations). This behavior was attributed to the formation 
of regions of stress concentration in the gel around the microspheres along with the 




Figure 4.8: Elastic moduli of PEGDA/HA hydrogels loaded with varying 
concentration of microspheres 
4.3.1 Cell adhesion on spin coated glass slides 
 Microscopic glass slides were spin coated with Strataprene® and PLGA in 
dichloromethane solutions. Cells were seeded at a density of 50,000 per well for a 
duration of 24 hours and adhesion to the Strataprene® was compared with PLGA and 
TCP control using DAPI and red phalloidin staining of fixed cells. 
 Tissue culture plastic control showed the highest degree of cell adhesion as 
evidenced by the high number of cell nuclei visualized using the DAPI stain. The cellular 
cytoskeleton also demonstrated a high degree of spreading as demonstrated by the 
staining of F – actin by red phalloidin. 
 
Figure 4.9: Fluorescent images of rat fibroblasts on TCP stained with a) DAPI, b) 
red phalloidin and c) DAPI and red phalloidin overlayed after 24 hours of culture. 
Scale bar: 400 um 
 PLGA coated glass slides showed a significantly lower number of cell nuclei on 
its surface when compared to the tissue culture plastic control. The cell morphology was 
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also quite different as there wasn’t as much cell spreading exhibited by the rat fibroblasts 
cultured on TCP. 
 
Figure 4.10: Fluorescent images of rat fibroblasts on PLGA stained with a) DAPI, b) 
red phalloidin and c) DAPI and red phalloidin overlayed after 24 hours of culture. 
Scale bar: 400 um 
 Strataprene® coated glass slides showed much better cell adhesion than PLGA. 
There were a greater number of cells with a more spread cytoskeletal morphology 
comparable to the behavior of rat fibroblasts on TCP.  
 
Figure 4.11: Fluorescent images of rat fibroblasts on Strataprene® stained 
with a) DAPI, b) red phalloidin and c) DAPI and red phalloidin overlayed after 24 
hours of culture. Scale bar: 400 um 
These studies show that cells can adhere to Strataprene® quite well without 
additional protein modification (e.g. coating with adhesion enhancers like fibronectin, 
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laminin etc). Adhesion to PLGA could be improved by fibronectin coating, but the 
benefit of using Strataprene® is the ability to support adhesion without this extra 
modification step that will either introduce animal derived proteins or human proteins 
that are very expensive. 
4.3.2 Cell seeding 
 Porous Strataprene® microspheres were seeded with rat fibroblast cells for a 
duration of 24 hours followed by live fluorescein diacetate staining. There appeared to be 
some cell attachment when the microspheres were transferred to a fresh well (Fig 4.9) 
without any cells. However, cell attachment wasn’t as decisive as we’d hoped for. It was 
hypothesized that this could be due to the presence of polyvinyl alcohol entrapped by the 
microspheres during emulsion stabilization interfering with cell adhesion. 
 
Figure 4.12: Fluorescent images of rat fibroblasts on Strataprene® microspheres in 
a) the same well they were seeded in b) after being transferred to separate wells. 






CONCLUSIONS AND FUTURE STUDIES 
5.1 CONCLUSIONS 
The goal of this project was to develop and characterize a novel porous polymer 
microsphere – hydrogel composite for tissue engineering based on cell therapy 
approaches. A novel polymer Strataprene® 3534 synthesized by Poly-Med, Inc. was 
chosen for the fabrication of porous polymer microspheres by double emulsion solvent 
evaporation due to its suitability for the cell scaffold application. Different batches with 
variations in process parameters were made in an attempt to obtain microspheres with 
diameters in the 300 – 450 µm range along with pore sizes in the 30 – 70 µm range. This 
was achieved by reducing polymer and increasing porogen (ammonium bicarbonate) 
concentrations. The uniformity of suspensions of both freeze dried and non-freeze dried 
microspheres in a 1X PBS solution and solution of PBS containing HA were evaluated. It 
was found that suspensions of non-freeze dried microspheres in a solution of 1X PBS 
containing 0.36% HA stayed uniform for 20 minutes at a time. 
 A Polyethylene glycol diacrylate (PEGDA) macromere blend of PEG-bis-
(acryloyloxy aceteate), PEG-bis-(acryloyloxy propanoate) and PEG-bis-(acryloyloxy 
butyrate) with hyaluronic acid was selected for the formulation of the hydrogel 
component of our composite system due to the permission of rapid and sustained cell 
spreading by this semi-interpenetrating polymer network (semi-IPN) along with control 
over rate of hydrolytic degradation. The PEGDA/HA semi-IPN was photopolymerized 
along with varying concentrations of porous polymeric microspheres and then 
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mechanically characterized in order to assess the structural integrity of the composite. 
The elastic moduli and gelation efficiencies of the composites were compared with 
hydrogel only controls. It was found that an increase in concentration of incorporated 
microparticles led to a decrease in the elastic moduli of the composites. The composites 
maintained their structure and exhibited relatively high elastic moduli of 26.43 ± 2.04 
kPa at 18mg/ml concentration. There was an increase in equilibrium water content and 
decrease in gel contents of the gel – microsphere composite with an increase in 
microsphere concentration. This behavior was attributed to a decrease in the efficiency of 
crosslinking and homogeneity of the network because of the presence of non-covalently 
incorporated microspheres. 
Preliminary tests to establish the proof of concept of our composite system were 
performed by seeding rat fibroblast cells onto Strataprene® films and comparing 
adhesion properties with poly (lactide-co-glycolide) films and tissue culture plastic 
controls. Strataprene® exhibited cell adhesion and spreading comparable to TCP and 
significantly greater than the PLGA control. Cells were also able to adhere to the porous 
Strataprene® microsphere component of our composite without the use of enhancers such 
as fibronectin. 
5.2 Future Studies 
 While the results of the pilot cell adhesion test on Strataprene® films were 
promising, cell adhesion to the porous Strataprene® microsphere component of our 
composite was not as efficient due to the presence of polyvinyl alcohol (PVA) used to 
stabilize the emulsion. Strategies such as surface chemical etching to eliminate PVA need 
 49 
to be examined. Alternatively, the use of emulsion stabilizers such as gelatin, more 
compatible with cell adhesion needs to be investigated [44]. The cell proliferation and 
ECM accumulation properties of the composite system also need to be evaluated for the 
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